Skip to main content
Top
Published in: Neurological Sciences 7/2022

08-03-2022 | Creutzfeldt-Jakob Disease | Original Article

Epidemiological and clinical characteristics of patients with late-onset Creutzfeldt-Jakob disease

Authors: Iliya Trachtenbroit, Oren S. Cohen, Joab Chapman, Hanna Rosenmann, Zeev Nitsan, Esther Kahana, Shmuel Appel

Published in: Neurological Sciences | Issue 7/2022

Login to get access

Abstract

Background

Creutzfeldt-Jacob disease (CJD) is a fatal neuro-degenerative disease, characterized by rapid and intense deterioration, mainly cognitive, leading to death. The typical onset of the disease is around the age of 67.

Purpose

To characterize the demographic and clinical features of the population of CJD patients with late-onset disease.

Methods

In this retrospective study, the Israeli national database of prion diseases was screened for CJD patients with disease age of onset > 80 years between 1960 and 2016. Patient’s demographic and clinical data were collected including sex, type of disease (sporadic/ genetic), clinical presentation, lab results including tau protein level, imaging, and EEG characteristics. Then, the clinical and demographic data of patients with late onset (> 80 years) (L) and patients with usual age of onset (< 80 years) (U) were compared.

Results

The study included 728 patients, 23 patients (3.3%) with late-onset disease (82.2.4±4 years, range 80–88) and 705 with usual disease onset (61.31 ± 9.47 years, range 34–80). Sporadic CJD was more common in the late-onset group (18/23 patients (78.2%) (L) vs. 256/705 patients (36.3%) (U)) (p = 0.0001, chi-square test). Classical EEG finding of periodic sharp wave activity were seen more often in the late-onset patients (55% (L) vs. 32.5% (U)) (p = 0.05, chi-square test). The rest of the demographic and clinical features were similar in both groups.

Conclusion

Late- and usual-onset diseases are similar in most of demographic and clinical features suggesting a common disease type with normal distribution of age of onset.
Literature
1.
go back to reference Millhauser GL (2004) Copper binding in the prion protein. Acc Chem Res 37:79–85CrossRef Millhauser GL (2004) Copper binding in the prion protein. Acc Chem Res 37:79–85CrossRef
2.
go back to reference Bremer J, Baumann F, Tiberi C et al (2010) Axonal prion protein is required for peripheral myelin maintenance. Nat Neurosci 13:310–318CrossRef Bremer J, Baumann F, Tiberi C et al (2010) Axonal prion protein is required for peripheral myelin maintenance. Nat Neurosci 13:310–318CrossRef
3.
go back to reference Wulf MA, Senatore A, Aguzzi A (2017) The biological function of the cellular prion protein: an update. BMC Biol 15(1):34CrossRef Wulf MA, Senatore A, Aguzzi A (2017) The biological function of the cellular prion protein: an update. BMC Biol 15(1):34CrossRef
5.
go back to reference Knight RS, Will RG (2004) Prion diseases. J Neurol Neurosurg Psychiatry 75:i36–i42CrossRef Knight RS, Will RG (2004) Prion diseases. J Neurol Neurosurg Psychiatry 75:i36–i42CrossRef
6.
go back to reference Goldfarb LG, Korczyn AD, Brown P, Chapman J, Gajdusek DC (1990) Mutation in codon 200 of scrapie amyloid precursor gene linked to Creutzfeldt-Jakob disease in Sephardic Jews of Libyan and non-Libyan origin. Lancet 336:637–638CrossRef Goldfarb LG, Korczyn AD, Brown P, Chapman J, Gajdusek DC (1990) Mutation in codon 200 of scrapie amyloid precursor gene linked to Creutzfeldt-Jakob disease in Sephardic Jews of Libyan and non-Libyan origin. Lancet 336:637–638CrossRef
7.
go back to reference Hsiao K, Meiner Z, Kahana E et al (1991) Mutation of the prion protein in Libyan Jews with Creutzfeldt-Jakob disease. N Engl J Med 324:1091–1097CrossRef Hsiao K, Meiner Z, Kahana E et al (1991) Mutation of the prion protein in Libyan Jews with Creutzfeldt-Jakob disease. N Engl J Med 324:1091–1097CrossRef
8.
go back to reference Korczyn AD (1991) Creutzfeldt-Jakob disease among Libyan Jews. Eur J Epidemiol 7:490–493CrossRef Korczyn AD (1991) Creutzfeldt-Jakob disease among Libyan Jews. Eur J Epidemiol 7:490–493CrossRef
9.
go back to reference Cali I, Cohen ML, Haik S et al (2018) Iatrogenic Creutzfeldt-Jakob disease with amyloid-β pathology: an international study. Acta Neuropathol Commun 6(1):5CrossRef Cali I, Cohen ML, Haik S et al (2018) Iatrogenic Creutzfeldt-Jakob disease with amyloid-β pathology: an international study. Acta Neuropathol Commun 6(1):5CrossRef
10.
go back to reference Croes EA, van Duijn CM (2003) Variant Creutzfeldt-Jakob disease. Eur J Epidemiol 18:473–477CrossRef Croes EA, van Duijn CM (2003) Variant Creutzfeldt-Jakob disease. Eur J Epidemiol 18:473–477CrossRef
11.
go back to reference Lundberg PO (1998) Creutzfeldt-Jakob disease in Sweden. J Neurol Neurosurg Psychiatry 65:836–841CrossRef Lundberg PO (1998) Creutzfeldt-Jakob disease in Sweden. J Neurol Neurosurg Psychiatry 65:836–841CrossRef
13.
go back to reference Gambetti P, Kong Q, Zou W, Parchi P, Chen SG (2003) Sporadic and familial CJD: classification and characterisation. Br Med Bull 66:213–239CrossRef Gambetti P, Kong Q, Zou W, Parchi P, Chen SG (2003) Sporadic and familial CJD: classification and characterisation. Br Med Bull 66:213–239CrossRef
14.
go back to reference Minikel E, Vallabh S, Orseth M et al (2019) Age at onset in genetic prion disease and the design of preventive clinical trials. Neurology 93(2):e125–e134CrossRef Minikel E, Vallabh S, Orseth M et al (2019) Age at onset in genetic prion disease and the design of preventive clinical trials. Neurology 93(2):e125–e134CrossRef
15.
go back to reference Knight R (2002) Epidemiology of variant CJD. Dev Biol (Basel) 108:87–92 Knight R (2002) Epidemiology of variant CJD. Dev Biol (Basel) 108:87–92
16.
go back to reference Corato M, Cereda C, Cova E, Ferrarese C, Ceroni M (2006) Young-onset CJD: age and disease phenotype in variant and sporadic forms. Funct Neurol 21:211–215PubMed Corato M, Cereda C, Cova E, Ferrarese C, Ceroni M (2006) Young-onset CJD: age and disease phenotype in variant and sporadic forms. Funct Neurol 21:211–215PubMed
17.
go back to reference Boesenberg C, Schulz-Schaeffer WJ, Meissner B et al (2005) Clinical course in young patients with sporadic Creutzfeldt-Jakob disease. Ann Neurol 58:533–543 CrossRef Boesenberg C, Schulz-Schaeffer WJ, Meissner B et al (2005) Clinical course in young patients with sporadic Creutzfeldt-Jakob disease. Ann Neurol 58:533–543 CrossRef
18.
go back to reference WHO (1998) Global surveillance, diagnosis and therapy of human transmissible spongiform encephalopathies: report of the WHO consultation. In: World health organization: emerging and other communicable diseases, surveillance and control, Geneva, pp 9–11 WHO (1998) Global surveillance, diagnosis and therapy of human transmissible spongiform encephalopathies: report of the WHO consultation. In: World health organization: emerging and other communicable diseases, surveillance and control, Geneva, pp 9–11
19.
go back to reference Hansen HC, Zschocke S, Sturenburg HJ, Kunze K (1998) Clinical changes and EEG patterns preceding the onset of periodic sharp wave complexes in Creutzfeldt-Jakob disease. Acta Neurol Scand 97:99–106CrossRef Hansen HC, Zschocke S, Sturenburg HJ, Kunze K (1998) Clinical changes and EEG patterns preceding the onset of periodic sharp wave complexes in Creutzfeldt-Jakob disease. Acta Neurol Scand 97:99–106CrossRef
20.
go back to reference Caobelli F, Cobelli M, Pizzocaro C, Pavia M, Magnaldi S, Guerra UP (2015) The role of neuroimaging in evaluating patients affected by Creutzfeldt-Jakob disease: a systematic review of the literature. J Neuroimaging. 25:2–13CrossRef Caobelli F, Cobelli M, Pizzocaro C, Pavia M, Magnaldi S, Guerra UP (2015) The role of neuroimaging in evaluating patients affected by Creutzfeldt-Jakob disease: a systematic review of the literature. J Neuroimaging. 25:2–13CrossRef
21.
go back to reference Nozaki I, Hamaguchi T, Sanjo N et al (2010) Prospective 10-year surveillance of human prion diseases in Japan. Brain 133:3043–3057CrossRef Nozaki I, Hamaguchi T, Sanjo N et al (2010) Prospective 10-year surveillance of human prion diseases in Japan. Brain 133:3043–3057CrossRef
22.
go back to reference Appel SA, Chapman J, Kahana E et al (2010) Rapidly progressive Creutzfeldt-Jakob disease in patients with Familial Mediterranean Fever. Eur J Neurol 17:861–865CrossRef Appel SA, Chapman J, Kahana E et al (2010) Rapidly progressive Creutzfeldt-Jakob disease in patients with Familial Mediterranean Fever. Eur J Neurol 17:861–865CrossRef
Metadata
Title
Epidemiological and clinical characteristics of patients with late-onset Creutzfeldt-Jakob disease
Authors
Iliya Trachtenbroit
Oren S. Cohen
Joab Chapman
Hanna Rosenmann
Zeev Nitsan
Esther Kahana
Shmuel Appel
Publication date
08-03-2022
Publisher
Springer International Publishing
Published in
Neurological Sciences / Issue 7/2022
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-022-05929-9

Other articles of this Issue 7/2022

Neurological Sciences 7/2022 Go to the issue